跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,630 条关于
“Schroders Capital”
全部
3,630
临床试验
626
药物
15
机构
107
资讯
2,882
2个月前
Ipsen Acquires Memo Therapeutics in Deal Worth Up to €700 Million, Validating Antibody Discovery Platform
10个月前
AAVantgarde Secures $141 Million Series B to Advance Gene Therapies for Stargardt Disease and Usher 1B Syndrome
7个月前
Kainova Therapeutics Raises $32M CAD to Advance GPCR-Targeting Cancer and Inflammation Therapies
11个月前
Draig Therapeutics Receives FDA Clearance for Phase 2 Trial of Novel AMPA Receptor Modulator DT-101 in Major Depressive Disorder
8个月前
Kinaset Therapeutics Secures $103 Million Series B to Advance Novel Inhaled JAK Inhibitor for Severe Asthma
10个月前
Artios Pharma Raises $115M Series D to Advance DNA Damage Response Cancer Therapies
2年前
iOnctura Secures €80 Million Series B to Advance PI3Kδ Cancer Therapy Through Phase II Trials
3个月前
Azafaros Publishes Phase 2 RAINBOW Study Data for Nizubaglustat in GM2 Gangliosidosis and Niemann-Pick Type C Disease
去年
Azafaros Secures €132M Series B Financing to Advance Rare Lysosomal Storage Disorder Treatments
去年
Draig Therapeutics Emerges from Stealth with $140M to Advance Novel Neuropsychiatric Therapies
第 1 页,共 289 页
上一页
下一页